What is the price of mivamutide? How do patients obtain medication and related insurance coverage?

Mifamurtide (Mifamurtide) is an immunomodulatory drug used to treat high-risk osteosarcoma. Its price varies depending on the region, pharmacy and purchase method. According to current market information, the price of mivamutide in pharmacies in Hong Kong is approximately 40,000 Hong Kong dollars per dose for 4 mg. This price may vary depending on drug availability, drug import costs and sellers.

Patients can obtain mivamutide through pharmacies or hospitals in Hong Kong, usually with a doctor's prescription. As a prescription drug, mivamutide cannot be purchased by patients at will and needs to be used under the guidance of a doctor. If the patient is in other regions, he may need to obtain it through international drug procurement channels, or he may purchase it through cross-border drug purchase channels.

Regarding insurance coverage of mivamutide, patients should first check with their health insurance company when purchasing the drug to see if the cost of mivamutide is covered. In most cases, medications to treat osteosarcoma may be covered by health insurance, especially those related to cancer treatment. However, reimbursement policies for cancer treatment drugs vary among regions and insurance companies, and some patients may need to go through a special application or approval process to obtain reimbursement for their drugs.

Some regional or national government-sponsored programs may provide subsidies or support for mivamutide, particularly in medical assistance programs for children and low-income patients. Patients can consult their local medical institutions or social welfare agencies to find out whether they can receive partial or full cost support for mivamutide through government funding.

In summary, the price of mivamutide is approximately 4mg around HK$40,000 per dose, but the specific cost will vary according to different regions and suppliers. Patients can obtain this drug through hospitals, pharmacies or cross-border purchase channels. It is also recommended to inquire with their insurance company whether the cost of the drug is covered and whether it is eligible for government funding.

xa0

References: https://pubmed.ncbi.nlm.nih.gov/23997016/